ARK Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

ARK Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,902,838	Closed	-$127M	–	303
2021 Q2	$127M	Sell	1,902,838 -277,081	-13%	-$18.1M	0.24%	79
2021 Q1	$138M	Buy	+2,179,919	New	+$136M	0.27%	76
2020 Q1	–	Sell	-53,054	Closed	-$3.41M	–	208
2019 Q4	$3.41M	Sell	53,054 -267,658	-83%	-$15.3M	0.09%	81
2019 Q3	$16.3M	Sell	320,712 -31,709	-9%	-$1.49M	0.36%	48
2019 Q2	$16M	Buy	352,421 +158,104	+81%	+$7.36M	0.4%	44
2019 Q1	$9.27M	Buy	+194,317	New	+$9.68M	0.26%	51
2018 Q4	–	Sell	-55,283	Closed	-$3.43M	–	196
2018 Q3	$3.43M	Buy	55,283 +17,136	+45%	+$1.02M	0.1%	81
2018 Q2	$2.11M	Buy	+38,147	New	+$2.06M	0.08%	85

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ARK Investment Management's BMY Position: Q3 2021 in Review

ARK Investment Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 1,902,838 shares — an estimated $127M sold.

ARK Investment Management first reported a position in BMY in Q2 2018 and held it in 8 quarters. The position peaked at $138M in Q1 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

ARK Investment Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
ARK Investment Management sold 1,902,838 Bristol-Myers Squibb shares in Q3 2021, an estimated $127M.
ARK Investment Management first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 8 quarters.
ARK Investment Management's Bristol-Myers Squibb position peaked at $138M in Q1 2021.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on ARK Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.